MedTrace Logo

Dexmedetomidine in Pediatric Tonsillectomy

NCT01057381 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2021-07-27

Study results available
· View outcomes & findings →

Summary

The hypothesis of this study is that the administration of an intra-operative dose of dexmedetomidine will result in adequate analgesia without respiratory depression thereby resulting in an early discharge from the post anesthetic care unit following adenotonsillectomy.

Conditions

  • Pediatric Adenotonsillectomy
  • Post Operative Analgesia

Interventions

DRUG

Dexmedetomidine 0.75 mcg/kg

Single intra-operative administration of dexmedetomidine 0.75 mcg/kg over 10 minutes for analgesia.

DRUG

Morphine 50 mcg/kg

Single intra-operative administration of morphine 50 mcg/kg over 10 minutes for analgesia

DRUG

Morphine 100 mcg/kg

Single intra-operative dose of morphine 100 mcg/kg over 10 minutes for analgesia

DRUG

Dexmedetomidine 1 mcg/kg

Single intra-operative administration of dexmedetomidine 1 mcg/kg over 10 minutes for analgesia

Sponsors & Collaborators

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Olutoyin A Olutoye, M.D. · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2010-11-30
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01057381 on ClinicalTrials.gov